Horm Metab Res 2023; 55(12): 819-826
DOI: 10.1055/a-2084-3561

Ferroptosis Signaling Pathways: Alzheimer's Disease

Shubhrat Maheshwari
1   Faculty of Pharmaceutical Sciences, Rama University, Kanpur, India
› Author Affiliations


The involvements of iron metabolism, lipid peroxidation, and oxidative stress in Alzheimer's disease (AD) development have recently received a lot of attention. We also observe that these pathogenic occurrences play a key role in regulating ferroptosis, a unique regulatory cell death that is iron-dependent, oxidative, and non-apoptotic. Iron is a crucial component that makes up a subunit of the oxidase responsible for lipid peroxidation. A family of non-heme iron enzymes known as lipoxygenases (LOXs) can cause ferroptosis by oxidising polyunsaturated fatty acids in cellular membranes (PUFAs). Toxic lipid hydroperoxides are produced in large part by the iron in LOX active sites. Deferoxamine and deferiprone, two iron chelators, could also treat ferroptosis by eliminating the crucial catalytic iron from LOXs. Phospholipids containing polyunsaturated fatty acids are the main substrates of lipid peroxidation in ferroptosis, which is favourably controlled by enzymes like ACSL4, LPCAT3, ALOXs, or POR. Selective stimulation of autophagic degradation pathways leads to an increase in iron accumulation and lipid peroxidation, which promotes ferroptosis. We highlighted recent advancements in our understanding of ferroptosis signaling routes in this study. One form of regulated necrotic cell death known as ferroptosis has been linked to a number of diseases, including cancer, neurological disorders, and ischemia/reperfusion injury. Cerebrospinal fluid (CSF) ferritin may be a good indicator of the amount of iron in the brain because it is the main protein that stores iron.

Publication History

Received: 04 April 2023

Accepted after revision: 21 April 2023

Article published online:
31 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References

  • 1 Zhang L, Fang J, Tang Z. et al. Bioinformatics perspective on the dysregulation of ferroptosis and ferroptosis-related immune cell infiltration in Alzheimer's disease. Int J Med Sci 2022; 19: 1888-1902
  • 2 Distéfano AM, López GA, Bauer V. et al. Ferroptosis in plants: regulation of lipid peroxidation and redox status. Biochem J 2022; 479: 857-866
  • 3 Shan K, Feng N, Zhu D. et al. Free docosahexaenoic acid promotes ferroptotic cell death via lipoxygenase dependent and independent pathways in cancer cells. Eur J Nutr 2022; 61: 4059-4075
  • 4 Chen Q, Zheng Q, Yang Y. et al. 12/15-Lipoxygenase regulation of diabetic cognitive dysfunction is determined by interfering with inflammation and cell apoptosis. Int J Mol Sci 2022; 23: 8997
  • 5 Mishima E, Ito J, Wu Z. et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 2022; 608: 778-783
  • 6 Wang X, Ma H, Sun J. et al. Mitochondrial ferritin deficiency promotes osteoblastic ferroptosis via mitophagy in type 2 diabetic osteoporosis. Biol Trace Elem Res 2022; 1
  • 7 Stockwell BR. et al. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 2022; 185: 2401-2421
  • 8 Xin S, Mueller C, Pfeiffer S. et al. MS4A15 drives ferroptosis resistance through calcium-restricted lipid remodeling. Cell Death Differ 2022; 29: 670-686
  • 9 Forcina GC, Pope L, Murray M. et al. Ferroptosis regulation by the NGLY1/NFE2L1 pathway. Proc Natl Acad Sci U S A 2022; 119: e2118646119
  • 10 Lei G, Zhuang L, Gan B. et al. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 2022; 22: 381-396
  • 11 Chen J, Li X, Ge C. et al. The multifaceted role of ferroptosis in liver disease. Cell Death Differ 2022; 29: 467-480
  • 12 Liu Y, Gu W.. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ 2022; 29: 895-910
  • 13 Koppula P, Lei G, Zhang Y. et al. A targetable CoQ-FSP1 axis drives ferroptosis-and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun 2022; 13: 2206
  • 14 Singh A, Ansari VA, Mahmood T. et al. Receptor for advanced glycation end products: dementia and cognitive impairment. Drug Res 2023; DOI: 10.1055/a-2015-8041. Online ahead of print
  • 15 Liang D, Minikes AM, Jiang X. et al. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 2022; 82: 2215-2227
  • 16 Li Z, Ferguson L, Deol KK. et al. Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability. Nat Chem Biol 2022; 18: 751-761
  • 17 Liu J, Kang R, Tang D. et al. Signaling pathways and defense mechanisms of ferroptosis. FEBS J 2022; 289: 7038-7050
  • 18 Singh A, Ansari VA, Mahmood T. et al. Dendrimers: a neuroprotective lead in Alzheimer disease: a review on its synthetic approach and applications. Drug Res 2022; 72: 417-423
  • 19 Niu X, Chen L, Li Y. et al. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: perspectives for immunotherapy of SCLC. Semin Cancer Biol 2022; 86: 273-285
  • 20 Singh A, Ansari VA, Mahmood T. et al. Neurodegeneration: Microglia: Nf-Kappab Signaling Pathways. Drug Res 2022; 72: 496-499
  • 21 Jo A, Bae JH, Yoon YJ. et al. Plasma-activated medium induces ferroptosis by depleting FSP1 in human lung cancer cells. Cell Death Dis 2022; 13: 212
  • 22 Cao F, Sang Y, Liu C. et al. Self-adaptive single-atom catalyst boosting selective ferroptosis in tumor cells. ACS Nano 2022; 16: 855-868
  • 23 Chen X, Huang J, Yu C. et al. Noncanonical function of EIF4E limits ALDH1B1 activity and increases susceptibility to ferroptosis. Nat Commun 2022; 13: 6318
  • 24 Pan WL, Tan Y, Meng W. et al. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework. Biomaterials 2022; 283: 121449
  • 25 Wang Y, Yan S, Liu X. et al. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway. Cell Death Differ 2022; 29: 1982-1995
  • 26 Tan Y, Huang Y, Mei R. et al. HucMSC-derived exosomes delivered BECN1 induces ferroptosis of hepatic stellate cells via regulating the xCT/GPX4 axis. Cell Death Dis 2022; 13: 319
  • 27 Wang WJ, Ling YY, Zhong YM. et al. Ferroptosis-enhanced cancer immunity by a ferrocene-appended iridium (III) Diphosphine complex. Angew Chem Int Ed 2022; 61: e202115247
  • 28 Yuan S, Wei C, Liu G. et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. Cell Prolifer 2022; 55: e13158
  • 29 Cui J, Zhou Q, Yu M. et al. 4-tert-Butylphenol triggers common carp hepatocytes ferroptosis via oxidative stress, iron overload, SLC7A11/GSH/GPX4 axis, and ATF4/HSPA5/GPX4 axis. Ecotoxicol Environ Saf 2022; 242: 113944
  • 30 Chen K, Jiang X, Wu M. et al. Ferroptosis, a potential therapeutic target in Alzheimer’s disease. Front Cell Develop Biol 2021; 9: 704298
  • 31 Zhang G, Zhang Y, Shen Y. et al. The potential role of ferroptosis in Alzheimer’s disease. J Alzheimer's Dis 2021; 80: 907-925
  • 32 Yan N, Zhang J. et al. Iron metabolism, ferroptosis, and the links with Alzheimer’s disease. Front Neurosci 2020; 13: 1443
  • 33 Bao WD, Pang P, Zhou XT. et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease. Cell Death Differ 2021; 28: 1548-1562
  • 34 Yan HF, Zou T, Tuo QZ. et al. Ferroptosis: mechanisms and links with diseases. Signal Transduc Target Therapy 2021; 6: 49
  • 35 Weiland A, Wang Y, Wu W. et al. Ferroptosis and its role in diverse brain diseases. Mol Neurobiol 2019; 56: 4880-4893
  • 36 Vitalakumar D, Sharma A, Flora SJ. et al. Ferroptosis: A potential therapeutic target for neurodegenerative diseases. J Biochem Mol Toxicol 2021; 35: e22830
  • 37 Li N, Yi X, He Y. et al. Targeting ferroptosis as a novel approach to alleviate aortic dissection. Int J Biol Sci 2022; 18: 4118-4134
  • 38 Lei J, Chen Z, Song S. et al. Insight into the role of ferroptosis in non-neoplastic neurological diseases. Front Cell Neurosci 2020; 14: 231
  • 39 Cheng Y, Song Y, Chen H. et al. Ferroptosis mediated by lipid reactive oxygen species: a possible causal link of neuroinflammation to neurological disorders. Oxid Med Cell Longev 2021; 2021: 1-3
  • 40 Sun Y, Yan C, He L. et al. Inhibition of ferroptosis through regulating neuronal calcium homeostasis: an emerging therapeutic target for Alzheimer’s disease. Age Res Rev 2023; 87: 101899
  • 41 Tang M, Chen Z, Wu D. et al. Ferritinophagy/ferroptosis: Iron-related newcomers in human diseases. J Cell Physiol 2018; 233: 9179-9190
  • 42 Qiu Y, Cao Y, Cao W. et al. The application of ferroptosis in diseases. Pharmacol Res 2020; 159: 104919
  • 43 Rogers JT, Cahill CM. et al. Iron-responsive-like elements and neurodegenerative ferroptosis. Learn Memory 2020; 27: 395-413
  • 44 Stockwell BR, Angeli JP, Bayir H. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017; 171: 273-285
  • 45 Wang S, Liao H, Li F. et al. A mini-review and perspective on ferroptosis-inducing strategies in cancer therapy. Chin Chem Lett 2019; 30: 847-852
  • 46 Musheshe N, Oun A, Sabogal-Guáqueta AM. et al. Pharmacological inhibition of Epac1 averts ferroptosis cell death by preserving mitochondrial Integrity. Antioxidants 2022; 11: 314
  • 47 Plascencia-Villa G, Perry G. et al. Implication of ferroptosis iron-dependent programmed cell death mechanism in neurodegeneration: molecular and cell biology/oxidative stress. Alzheimer Dement 2020; 16: e043978
  • 48 Li J, Li M, Ge Y. et al. β-Amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease. Cell Biosci 2022; 12: 69
  • 49 Sun W, Yan J, Ma H. et al. Autophagy-dependent ferroptosis-related signature is closely associated with the prognosis and tumor immune escape of patients with glioma. Int J Gen Med 2022; 253-270
  • 50 Liu L, Yang S, Wang H. et al. α-Lipoic acid alleviates ferroptosis in the MPP+-induced PC12 cells via activating the PI3K/Akt/Nrf2 pathway. Cell Biol Int 2021; 45: 422-431
  • 51 Wu L, Xian X, Tan Z. et al. The role of iron metabolism, lipid metabolism, and redox homeostasis in Alzheimer’s disease: from the perspective of ferroptosis. Mol Neurobiol 2023; 1-9
  • 52 Hassannia B, Van Coillie S, Vanden Berghe T. et al. Ferroptosis: biological rust of lipid membranes. Antioxid Redox Signal 2021; 35: 487-509
  • 53 Lei G, Zhang Y, Hong T. et al. Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity. Oncogene 2021; 40: 3533-3547
  • 54 Zhou X, Tang X, Li T. et al. Inhibition of VDAC1 rescues Aβ 1-42-induced mitochondrial dysfunction and ferroptosis via activation of AMPK and Wnt/β-catenin Pathways. Mediat Inflam 2023; 6739691 DOI: 10.1155/2023/67396912023.
  • 55 Reichert CO, de Freitas FA, Sampaio-Silva J. et al. Ferroptosis mechanisms involved in neurodegenerative diseases. Int J Mol Sci 2020; 21: 8765
  • 56 Xie Z, Wang X, Luo X. et al. Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis. Biochem Pharmacol 2023; 207: 115374